Connection

Elizabeth Garrett-Mayer to Erythema

Back to Details
This is a "connection" page, showing publications Elizabeth Garrett-Mayer has written about Erythema.
Elizabeth Garrett-Mayer
Connection Strength
0.013
Erythema
  1. A phase I toxicity and feasibility trial of sequential dose-dense induction chemotherapy with doxorubicin, paclitaxel, and 5-fluorouracil followed by high dose consolidation for high-risk primary breast cancer. Breast Cancer Res Treat. 2002 Nov; 76(2):145-56.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.